查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947770

工程蚊蟲防治市場分析及預測（至2035年）：依類型、產品、服務、技術、應用、最終使用者、流程、部署及解決方案分類

Engineered Mosquito Control Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Process, Deployment, Solutions
出版日期: | 出版商: Global Insight Services | 英文 384 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到2034年，基因工程蚊蟲控制市場規模將從2024年的5.616億美元成長至7.621億美元，年複合成長率約為3.1%。該市場涵蓋旨在減少蚊蟲數量和蚊媒疾病的創新生物技術解決方案，包括基因改造蚊子、不孕昆蟲技術和微生物控制方法。隨著瘧疾和登革熱等媒介傳播疾病日益成為全球健康挑戰，對永續且有針對性的蚊蟲控制解決方案的需求也日益成長。基因工程技術的進步、監管支持以及公共衛生資金的增加正在推動市場發展，凸顯了這一關鍵領域的成長機會。

由於對有效病媒控制方案的迫切需求，工程蚊蟲控制市場正經歷強勁成長。生物防治領域處於主導，基因改造蚊子在減少蚊媒疾病方面展現出良好的效果。不孕昆蟲技術（SIT）是該領域的重要細分市場，因其環保特性而日益受到關注。化學防治也緊隨其後，針對蚊子幼蟲和成蟲的創新殺蟲劑不斷湧現。生物農藥已成為關鍵的細分市場，反映出人們對永續害蟲防治方案的日益青睞。

市場區隔
類型 遺傳控制、生物控制、機械控制、化學控制
產品 基因改造蚊子、生物殺蟲劑、蚊子誘捕器、殺幼蟲劑、殺成蟲劑、昆蟲生長調節劑、驅蚊劑
服務 現場測試、監測、諮詢、法規遵循
科技 CRISPR基因編輯技術、不孕昆蟲技術、 RNA干擾技術、沃爾巴克氏體方法
應用領域 公共衛生、農業、住宅和商業
最終用戶 政府機構、非政府組織、研究機構、農業部門和衛生設施
流程 昆蟲釋放、田間監測和數據分析
如何安裝 本地、遠端
解決方案 綜合蟲害管理，單一解決方案

數位技術在蚊蟲控制策略中的應用也活性化了市場動態。遙感探測和數據分析工具正在最佳化蚊蟲監測和控制活動。公共衛生措施推動了對綜合蚊蟲控制方案的需求。對研發的加速投入促進了生技公司與公共衛生機構之間的合作。這些趨勢為市場持續擴張和創新提供了可能。

基因改造蚊蟲控制市場正經歷市場佔有率、定價策略和產品創新方面的動態變化。各公司日益注重開發兼顧都市區和農村地區的具成本效益解決方案。新產品的推出強調環保和永續理念，反映了人們日益增強的環保意識。此市場產品種類繁多，均旨在為蚊媒疾病提供有效的解決方案。隨著消費者意識的提高，定價策略競爭日益激烈，各公司都在努力平衡價格優勢與先進技術。

工程蚊蟲控制市場競爭異常激烈，主要企業不斷進行標竿對比，以維持競爭優勢。監管影響至關重要，北美和歐洲等地區對產品核可和使用制定了嚴格的標準。這些法規既可能抑制創新，也可能促進創新，這取決於企業如何適應。此外，生技公司與政府機構之間的合作也不斷加強，旨在提高產品的功效和覆蓋範圍。隨著市場的發展，了解這些競爭動態和法律規範對於策略定位和成長至關重要。

主要趨勢和促進因素：

由於人們對蚊媒疾病的日益關注，基因工程蚊蟲控制市場正經歷強勁成長。一個關鍵趨勢是採用基因工程技術培育能夠抑制蚊蟲數量和疾病傳播的蚊株。各國政府和衛生組織正投資研發創新的蚊蟲防治方法，以對抗瘧疾和登革熱等疾病。

技術進步使得蚊蟲控制方案更加精準有效。 CRISPR技術的開發促進了基因改造蚊子的培育，這些蚊子經過基因改造，可用於控制蚊蟲數量或預防疾病傳播。公眾接受度和監管部門的核准是影響市場趨勢的關鍵因素。

此外，公共衛生機構與生技公司之間的合作正在促進創新。這些夥伴關係旨在開發永續且擴充性的解決方案。隨著全球對有效蚊蟲控制方案的認知和需求不斷成長，預計市場將顯著成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 基因調控
    • 生物防治
    • 機械控制
    • 化學防治
  • 市場規模及預測：依產品分類
    • 基因改造蚊子
    • 生物農藥
    • 蚊子誘捕器
    • 殺幼蟲劑
    • 殺成蟲劑
    • 昆蟲生長調節劑
    • 驅蟲劑
  • 市場規模及預測：依服務分類
    • 實地測試
    • 監測/監控
    • 諮詢
    • 監理合規
  • 市場規模及預測：依技術分類
    • CRISPR基因編輯
    • 不孕昆蟲技術
    • RNA干擾
    • 沃爾巴克氏體法案
  • 市場規模及預測：依應用領域分類
    • 公共衛生
    • 農業
    • 住宅
    • 商業
  • 市場規模及預測：依最終用戶分類
    • 政府機構
    • 非政府組織（NGO）
    • 研究所
    • 農業
    • 醫療設施
  • 市場規模及預測：依製程分類
    • 昆蟲釋放
    • 現場監測
    • 數據分析
  • 市場規模及預測：依發展狀況
    • 當地的
    • 偏僻的
  • 市場規模及預測：按解決方案分類
    • 綜合蟲害管理
    • 獨立解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Oxitec
  • Intrexon
  • Mosquito Mate
  • Verily Life Sciences
  • Bio Mosquito
  • Skeeter Control
  • Vestergaard
  • Arctech Innovation
  • In2 Care
  • Ginkgo Bioworks
  • M2 M Biotechnologies
  • Bayer Crop Science Biologics
  • Geneworks
  • Aqua Bounty Technologies
  • Eden Research
  • Provivi
  • Senes Tech
  • Adapco
  • Clarke Mosquito Control
  • Valent Bio Sciences

第9章：關於我們

簡介目錄
Product Code: GIS10955

Engineered Mosquito Control Market is anticipated to expand from $561.6 million in 2024 to $762.1 million by 2034, growing at a CAGR of approximately 3.1%. The Engineered Mosquito Control Market encompasses innovative biotechnological solutions aimed at reducing mosquito populations and the diseases they transmit. This market includes genetically modified mosquitoes, sterile insect techniques, and microbial control methods. As vector-borne diseases like malaria and dengue pose significant global health challenges, demand for sustainable, targeted mosquito control solutions is rising. The market is driven by advancements in genetic engineering, regulatory support, and increased public health funding, highlighting opportunities for growth and development in this critical sector.

The Engineered Mosquito Control Market is experiencing robust growth, driven by the urgent need for effective vector control solutions. The biological control segment is leading, with genetically modified mosquitoes offering promising results in reducing mosquito-borne diseases. Sterile insect technique (SIT) is a key sub-segment, gaining traction due to its environmentally friendly approach. Chemical control follows closely, with the development of innovative insecticides that target mosquito larvae and adults. Biopesticides are emerging as a significant sub-segment, reflecting an increasing preference for sustainable pest management solutions.

Market Segmentation
TypeGenetic Control, Biological Control, Mechanical Control, Chemical Control
ProductGenetically Modified Mosquitoes, Biopesticides, Mosquito Traps, Larvicides, Adulticides, Insect Growth Regulators, Repellents
ServicesField Trials, Monitoring & Surveillance, Consulting, Regulatory Compliance
TechnologyCRISPR Gene Editing, Sterile Insect Technique, RNA Interference, Wolbachia Method
ApplicationPublic Health, Agriculture, Residential, Commercial
End UserGovernment Agencies, Non-Governmental Organizations, Research Institutions, Agricultural Sector, Healthcare Facilities
ProcessRelease of Insects, Field Monitoring, Data Analysis
DeploymentOn-Site, Remote
SolutionsIntegrated Pest Management, Standalone Solutions

The integration of digital technology in mosquito control strategies is also enhancing market dynamics. Remote sensing and data analytics tools are optimizing mosquito surveillance and intervention efforts. Public health initiatives are boosting demand for integrated mosquito management programs. The focus on research and development is accelerating, fostering collaborations between biotech firms and public health organizations. These trends underscore the market's potential for continued expansion and innovation.

The Engineered Mosquito Control Market is witnessing a dynamic shift in market share, pricing strategies, and product innovations. Companies are increasingly focusing on developing cost-effective solutions that cater to both urban and rural areas. New product launches are emphasizing eco-friendly and sustainable approaches, reflecting a broader trend towards environmental consciousness. The market is characterized by a diverse range of offerings, each aiming to provide effective solutions to mosquito-borne diseases. As consumer awareness grows, pricing strategies are becoming more competitive, with companies striving to balance affordability and advanced technology.

Competition in the Engineered Mosquito Control Market is intensifying, with key players continuously benchmarking against each other to maintain a competitive edge. Regulatory influences play a significant role, as policies in regions like North America and Europe set stringent standards for product approval and usage. These regulations can both hinder and drive innovation, depending on the adaptability of companies. The market is also witnessing collaborations between biotech firms and governmental bodies, aiming to enhance product efficacy and reach. As the market evolves, understanding these competitive dynamics and regulatory frameworks is crucial for strategic positioning and growth.

Tariff Impact:

Global tariffs and geopolitical tensions are critically influencing the Engineered Mosquito Control Market, particularly in East Asia. Japan and South Korea, traditionally reliant on imports, are now investing in local biotech innovations to mitigate tariff impacts. China is accelerating its domestic mosquito control technologies, driven by export restrictions and a strategic pivot towards self-reliance. Taiwan, while a key player in biotech manufacturing, navigates geopolitical uncertainties with cautious alliances. The parent market is witnessing robust growth, propelled by rising demand for vector control solutions amid climate change. By 2035, the market is projected to thrive, contingent on regional collaborations and technological advancements. Middle East conflicts, though less directly impactful, could disrupt global supply chains and energy prices, indirectly influencing production costs and market dynamics.

Geographical Overview:

The engineered mosquito control market is witnessing dynamic growth across various regions, each presenting unique opportunities. North America leads the sector, driven by advanced biotechnology research and proactive vector control initiatives. The region's focus on public health safety and innovation paves the way for significant market expansion. Europe follows closely, with stringent regulatory frameworks supporting sustainable mosquito control solutions.

The region's commitment to environmental sustainability and public health protection enhances its market potential. In Asia Pacific, the market is rapidly expanding, propelled by increasing urbanization and rising awareness about mosquito-borne diseases. Countries like India and China are emerging as key players, investing in innovative mosquito control technologies. Latin America and the Middle East & Africa present promising growth pockets. In Latin America, heightened government efforts to curb mosquito-borne illnesses drive market demand, while the Middle East & Africa recognize the need for effective mosquito control solutions to safeguard public health and support economic development.

Key Trends and Drivers:

The engineered mosquito control market is experiencing robust growth driven by increasing concerns about mosquito-borne diseases. Key trends include the adoption of genetic engineering techniques to develop mosquito strains that can reduce populations or transmission of diseases. Governments and health organizations are investing in innovative mosquito control methods to combat diseases like malaria and dengue.

Technological advancements are enabling more precise and effective mosquito control solutions. The development of CRISPR technology has facilitated the creation of genetically modified mosquitoes. These mosquitoes are designed to either suppress populations or prevent disease transmission. Public acceptance and regulatory approvals are crucial drivers that influence the market's trajectory.

Furthermore, collaborations between public health bodies and biotech companies are fostering innovation. These partnerships aim to develop sustainable and scalable solutions. The market is poised for significant growth as awareness and demand for effective mosquito control solutions continue to rise globally.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Genetic Control
    • 4.1.2 Biological Control
    • 4.1.3 Mechanical Control
    • 4.1.4 Chemical Control
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Genetically Modified Mosquitoes
    • 4.2.2 Biopesticides
    • 4.2.3 Mosquito Traps
    • 4.2.4 Larvicides
    • 4.2.5 Adulticides
    • 4.2.6 Insect Growth Regulators
    • 4.2.7 Repellents
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Field Trials
    • 4.3.2 Monitoring & Surveillance
    • 4.3.3 Consulting
    • 4.3.4 Regulatory Compliance
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 CRISPR Gene Editing
    • 4.4.2 Sterile Insect Technique
    • 4.4.3 RNA Interference
    • 4.4.4 Wolbachia Method
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Public Health
    • 4.5.2 Agriculture
    • 4.5.3 Residential
    • 4.5.4 Commercial
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Government Agencies
    • 4.6.2 Non-Governmental Organizations
    • 4.6.3 Research Institutions
    • 4.6.4 Agricultural Sector
    • 4.6.5 Healthcare Facilities
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Release of Insects
    • 4.7.2 Field Monitoring
    • 4.7.3 Data Analysis
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-Site
    • 4.8.2 Remote
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Integrated Pest Management
    • 4.9.2 Standalone Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Deployment
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Deployment
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Deployment
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Deployment
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Deployment
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Deployment
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Deployment
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Deployment
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Deployment
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Deployment
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Deployment
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Deployment
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Deployment
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Deployment
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Deployment
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Deployment
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Deployment
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Deployment
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Deployment
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Deployment
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Deployment
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Deployment
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Deployment
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Deployment
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Oxitec
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Intrexon
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Mosquito Mate
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Verily Life Sciences
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Bio Mosquito
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Skeeter Control
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Vestergaard
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Arctech Innovation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 In2 Care
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Ginkgo Bioworks
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 M2 M Biotechnologies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Bayer Crop Science Biologics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Geneworks
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Aqua Bounty Technologies
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Eden Research
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Provivi
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Senes Tech
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Adapco
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Clarke Mosquito Control
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Valent Bio Sciences
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us